Electromagnetic field‑inducible gene switch: a non‑invasive platform for remote spatiotemporal gene control

In a recent study published in Cell , Kim et al. present a remotely controlled, electromagnetic field (EMF)-inducible gene switch, termed the Ei switch, that enables precise spatiotemporal activation of transgene expression in vivo without pharmacological agents or invasive procedures. 1 By engineering a 450-bp EMF-responsive DNA element (Ei) derived from the leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) promoter, the authors established a transcriptional platform selectively responsive to extremely low-frequency EMF (EL-EMF) under the tested conditions, offering a non-invasive and reversible mode of gene regulation with the potential to address key limitations of optogenetics (limited tissue penetration) and reduce reliance on pharmacological inducers such as tetracycline-responsive systems. 1 , 2 , 3

Authors

Institutions

Publication Details

Journal
Signal Transduction and Targeted Therapy
Published
2026-08-20
DOI
https://doi.org/10.1038/s41392-026-02898-9
Primary Topic
Electromagnetic Fields and Biological Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Electromagnetic field‑inducible gene switch: a non‑invasive platform for remote spatiotemporal gene control

Hae-Jun Yang, Young‐Ho Park, MinYoung Kim
Signal Transduction and Targeted Therapy
Electromagnetic Fields and Biological Effects
article

Electromagnetic field‑inducible gene switch: a non‑invasive platform for remote spatiotemporal gene control

Hae-Jun Yang, Young‐Ho Park, MinYoung Kim
article en

Abstract

In a recent study published in Cell , Kim et al. present a remotely controlled, electromagnetic field (EMF)-inducible gene switch, termed the Ei switch, that enables precise spatiotemporal activation of transgene expression in vivo without pharmacological agents or invasive procedures. 1 By engineering a 450-bp EMF-responsive DNA element (Ei) derived from the leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) promoter, the authors established a transcriptional platform selectively responsive to extremely low-frequency EMF (EL-EMF) under the tested conditions, offering a non-invasive and reversible mode of gene regulation with the potential to address key limitations of optogenetics (limited tissue penetration) and reduce reliance on pharmacological inducers such as tetracycline-responsive systems. 1 , 2 , 3

Signal Transduction and Targeted TherapyVol. 11(1)
CHA University Bundang Medical Center (KR), Korea Research Institute of Bioscience and Biotechnology (KR), Korea University of Science and Technology (KR)
National Research Foundation, Korea Health Industry Development Institute, Korea Research Institute of Bioscience and Biotechnology, National Research Foundation of Korea, National Research Council of Science and Technology, Ministry of Science and ICT, South Korea
Openalex Percentile: Top 11%
Electromagnetic Fields and Biological Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.